Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
YishenShujin Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Fibromyalgia Syndrome
1 trial -
active nicotine gum
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
active tDCS and cognitive training intervention
United Therapeutics Europe Ltd
Brain Concussion
2 trials -
bovine Lactoferrin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nosocomial Infections
1 trial -
conventional radiotherapy 74 Gy delivered in 37 fractions
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
estradiol plus progesterone 100 mg IM injection
Universal Integrated
IVF
1 trial -
extended release niacin
United Therapeutics Europe Ltd
HIV Infections
1 trial -
high-energy digestible food E2
The First People's Hospital of Lianyungang
Caesarean Section
1 trial -
insulin injection 15 minutes before meals
The First People's Hospital of Lianyungang
Diabetes
1 trial -
irinotecan hydrochloride liposome injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Biliary Tract Carcinoma
1 trial -
mitomycin C
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obstructive Airway Disease
1 trial -
modified Ma Xing Shi Gan Decoction
Universal Integrated
Chronic Obstructive Pulmonary Disease
1 trial -
new infant formula
United Therapeutics Europe Ltd
Functional Constipation
1 trial -
postbiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ADHD - Attention Deficit Disorder With Hyperactivity
1 trial -
pure give pectin 20g/d for five days
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Inflammatory Bowel Disease
1 trial -
remimazolam
Xiyuan Hospital of China Academy of Chinese Medical Sciences
General Anesthetic Drug Adverse Reaction
1 trial -
repetitive transcranial magnetic stimulation (rTMS)
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine Addiction
1 trial -
salvianolate injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Angina, Stable
1 trial -
stereotactic body radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer
1 trial -
stereotactic radiosurgery
United Therapeutics Europe Ltd
Head and Neck Cancer
1 trial -
the traditional Chinese medicine prescription ' Shenzhuo Decoction '
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Kidney Disease (DKD)
1 trial -
thioctic acid
Ultragenyx UK Limited
Mitochondrial Myopathy
1 trial -
treatment with or without colistin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carbapenem-Resistant Enterobacteriaceae Infection
1 trial -
zinc
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources